ARQT vs CMS · rev $196.5M vs P/E 20, $22.42B cap
Arcutis Biotherapeutics Inc (ARQT) versus CMS Energy Corporation (CMS) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Latest reported ARQT revenue for 2024-12-31 was $196.5M. Net income was -$140.0M. Revenue was up 229.7% from 2023-12-31 to 2024-12-31. ARQT currently screens at market cap $1.64B.
CMS does not have a complete income-statement cache yet.
ARQT currently screens at market cap $1.64B. CMS currently screens at market cap $22.42B and trailing P/E 20.1.
Not investment advice. Open the ARQT and CMS stock pages for the full models.
Not investment advice.